The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Dianette 2 mg/35 microgram coated tablets



Lexon Pharmaceuticals (Ireland) LimitedPPA23176/033/001

Main Information

Trade NameDianette 2 mg/35 microgram coated tablets
Active SubstancesCYPROTERONE ACETATE
Ethinylestradiol
Dosage FormCoated tablet
Licence HolderLexon Pharmaceuticals (Ireland) Limited
Licence NumberPPA23176/033/001

Group Information

ATC CodeG03HB01 cyproterone and estrogen

Status

License statusAuthorised
Licence Issued14/08/2020
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back